Clinical and genetic characteristics of XIAP deficiency in Japan

Journal of Clinical Immunology

Volumn 32, Issue 3, 2012, Pages 411-420

  Yang, Xi ^a,b   Kanegane, Hirokazu ^a   Nishida, Naonori ^a   Imamura, Toshihiko ^c   Hamamoto, Kazuko ^d   Miyashita, Ritsuko ^e   Imai, Kohsuke ^f   Nonoyama, Shigeaki ^f   Sanayama, Kazunori ^g   Yamaide, Akiko ^h   Kato, Fumiyo ⁱ   Nagai, Kozo ^j   Ishii, Eiichi ^j   Van Zelm, Menno C ^k   Latour, Sylvain ^l   Zhao, Xiao Dong ^b   Miyawaki, Toshio ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^e Izumiotsu Municipal Hospital   (Japan)

^f NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^g NARITA RED CROSS HOSPITAL   (Japan)

^h CHIBA CHILDREN'S HOSPITAL   (Japan)

ⁱ TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^j EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^k ERASMUS MEDICAL CENTER   (Netherlands)

^l HÔPITAL NECKER ENFANTS MALADES   (France)

more..

Author keywords

Epstein Barr virus; hemophagocytic lymphohistiocytosis; invariant natural killer T cell; X linked inhibitor of apoptosis; X linked lymphoproliferative syndrome

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; DEXAMETHASONE; IMMUNOGLOBULIN G; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; X LINKED INHIBITOR OF APOPTOSIS;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COLITIS; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOPENIA; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS INFECTION; FAMILY HISTORY; FEMALE; FEVER; FRAMESHIFT MUTATION; GENE; GENE DELETION; GENETIC ANALYSIS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HETEROZYGOTE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; INFANT; INHERITANCE; JAPANESE; LYMPHOCYTE COUNT; MALE; MUTATIONAL ANALYSIS; NATURAL KILLER CELL; NONSENSE MUTATION; ONSET AGE; OTITIS MEDIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SPLENOMEGALY; STOP CODON; X LINKED INHIBITOR OF APOPTOSIS DEFICIENCY; X LINKED INHIBITOR OF APOPTOSIS GENE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; JAPAN; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; LYMPHOPROLIFERATIVE DISORDERS; MALE; MUTATION; NATURAL KILLER T-CELLS; T-LYMPHOCYTES, CYTOTOXIC; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84861478482     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-011-9638-z     Document Type: Article

References (38)

1. Sumegi J, Huang D, Lanyi A, Davis JD, Seemayer TA, Maeda A, et al. Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood. 2000;96:3118-25.
2. Seemayer TA, Gross TG, Egeler RM, Pirruccello SJ, Davis JR, Kelly CM, et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res. 1995;38:471-8.
3. Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 1998;395:462-9. (Pubitemid 28462434)
4. Coffey AJ, Brooksbank RA, Brandau O, Oohashi T, Howell GR, Bye JM, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet. 1998;20:129-35. (Pubitemid 28455444)
5. Nichols KE, Harkin DP, Levitz S, Krainer M, Kolquist KA, Genovese C, et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci USA. 1998;95:13765-70. (Pubitemid 28523047)
6. Gilmour KC, Cranston T, Jones A, Davies EG, Goldblatt D, Thrasher A, et al. Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression. Eur J Immunol. 2000;30:1691-7. (Pubitemid 30342812)
7. Rigaud S, Fondanèche MC, Lambert N, Pasquier B, Mateo V, Soulas P, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006;444:110-4. (Pubitemid 44684766)
8. Uren AG, Pakusch M, Hawkins CJ, Puls KL, Vaux DL. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci USA. 1996;93:4974-8.
9. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature. 1996;379:349-53. (Pubitemid 26033078)
10. Duckett CS, Nava VE, Gedrich RW, Clem RJ, van Dongen JL, Gilfillan MC, et al. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J. 1996;15:2685-94. (Pubitemid 26176246)
11. Galbán S, Duckett CS. XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ. 2010;17:54-60.
12. Marsh RA, Madden L, Kitchen BJ, Mody R, McClimon B, Jordan MB, et al. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood. 2010;7:1079-82.
13. Pachlopnik Schmid J, Canioni D, Moshous D, Touzot F, Mahlaoui N, Hauck F, et al. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP-deficiency) versus type 2 (XLP-2/XIAPdeficiency). Blood. 2011;117:1522-9.
14. Zhao M, Kanegane H, Ouchi K, Imamura T, Latour S, Miyawaki T. A novel XIAP mutation in a Japanese boy with recurrent pancytopenia and splenomegaly. Haematologica. 2010;95:688-9.
15. Filipovich AH, Zhang K, Snow AL, Marsh RA. X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood. 2010;116:3398-408.
16. Marsh RA, Villanueva J, Zhang K, Snow AL, Su HC, Madden L, et al. A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency. Cytometry B Clin Cytom. 2009;76:334-44.
17. Marsh RA, Bleesing JJ, Filipovich AH. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency. J Immunol Methods. 2010;362:1-9.
18. Yasukawa M, Ohminami H, Arai J, Kasahara Y, Ishida Y, Fujita S. Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans. Blood. 2000;95:2352-5. (Pubitemid 30167735)
19. Yanai F, Ishii E, Kojima K, Hasegawa A, Azuma T, Hirose S, et al. Essential roles of perforin in antigen-specific cytotoxity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells. J Immunol. 2003;170:2205-13. (Pubitemid 36197445)
20. Ishii E, Ueda I, Shirakawa R, Yamamoto K, Horiuchi H, Ohga S, et al. Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions. Blood. 2005;105:3442-8. (Pubitemid 40628184)
21. Nichols KE, Hom J, Gong SY, Ganguly A, Ma CS, Cannons JL, et al. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat Med. 2005;11:340-5. (Pubitemid 40460564)
22. Pasquier B, Yin L, Fondanéche MC, Relouzat F, Bloch- Queyrat C, Lambert N, et al. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J Exp Med. 2005;201:695-701. (Pubitemid 40395115)
23. Marsh RA, Villanueva J, Kim MO, Zhang K, Marmer D, Risma KA, et al. Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations. Clin Immunol. 2009;132:116-23.
24. Puck JM, Pepper AE, Bedard PM, Laframboise R. Female germ line mosaicism as the origin of a unique IL-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficienc. J Clin Invest. 1995;95:895-9.
25. O'Marcaigh A, Puck JM, Pepper AE, Santes KD, Cowan MJ. Maternal mosaicism for a novel interleukin-2 receptor gammachain mutation causing X-linked severe combined immunodeficiency in a Navajo kindred. J Clin Immunol. 1997;17:29-33. (Pubitemid 27083452)
26. Sakamoto M, Kanegane H, Fujii H, Tsukada S, Miyawaki T, Shinomiya N. Maternal germinal mosaicism of X-linked agammaglobulinemia. Am J Med Genet. 2001;99:234-7. (Pubitemid 32206962)
27. Harlin H, Reffey SB, Duckett CS, Lindsten T, Thompson CB. Characterization of XIAP-deficient mice. Mol Cell Biol. 2001;21:3604-8. (Pubitemid 32381796)
28. Latour S. Natural killer T cells and X-linked lymphoproliferative syndrome. Curr Opin Allergy Clin Immunol. 2007;7:510-4. (Pubitemid 350076446)
29. Schimmer AD, Dalili S, Batey RA, Riedl SJ. Targeting XIAP for the treatment of malignancy. Cell Death Differ. 2006;13:179-88. (Pubitemid 43102202)
30. Oliveira JB, Notarangelo LD, Fleisher TA. Applications of flow cytometry for the study of primary immune deficiencies. Curr Opin Allergy Clin Immunol. 2008;8:499-509.
31. Kanegane H, Futatani T, Wang Y, Nomura K, Shinozaki K, Matsukura H, et al. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis. J Allergy Clin Immunol. 2001;108:1012-20. (Pubitemid 33151556)
32. Godfrey DI, Berzins SP. Control points in NKT-cell development. Nat Rev Immunol. 2007;7:505-18. (Pubitemid 46987785)
33. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol. 2007;25:297-336. (Pubitemid 46697911)
34. Bauler LD, Duckett CS, O'Riordan MX. XIAP regulates cytosol-specific immunity to Listeria infection. PLoS Pathog. 2008;4:e1000142.
35. Hersperger AR, Makedonas G, Betts MR. Flow cytometric detection of perforin upregulation in human CD8 T cells. Cytometry A. 2008;73:1050-7.
36. Motyka B, Korbutt G, Pinkoski MJ, Heibein JA, Caputo A, Hobman M, et al. Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell. 2000;103:491-500.
37. Martin SJ, Amarante-Mendes GP, Shi L, Chuang TH, Casiano CA, O'Brien GA, et al. The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism. EMBO J. 1996;15:2407-16. (Pubitemid 26151180)
38. zur Stadt U, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet. 2009;85:482-92.